Verici DX (VRCI) Share Price

Health Care Sector


NOTE: This is based on 10 open tips for Verici DX (VRCI)


Verici DX (VRCI)
Latest Quote Price

2.38p

Verici DX (VRCI)
Price Change (%)

-2.17%


Latest Bid : 2.25p Latest Ask : 2.50p
High Today : 2.48p Low Today : 2.32p
This Years High : 11.75p This Years Low : 2.32p
Volume : 215,225 MKT Cap : £5.76M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Verici DX (VRCI) Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

Verici DX (VRCI) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 52.50%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 72.06%
Avoid Steve Moore Premium Only 2023-11-15 14:35:00 15/11/2023 73.61%
Avoid Steve Moore Premium Only 2023-07-20 16:25:00 20/07/2023 79.35%
Watch Steve Moore Premium Only 2023-07-03 11:40:00 03/07/2023

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Verici DX (VRCI) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 2.25p Latest Ask : 2.50p
High Today : 2.48p Low Today : 2.32p
This Years High : 11.75p This Years Low : 2.32p
Volume : 215,225 MKT Cap : £5.76M

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Verici DX Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 52.50%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 72.06%
Avoid Steve Moore Premium Only 2023-11-15 14:35:00 15/11/2023 73.61%
Avoid Steve Moore Premium Only 2023-07-20 16:25:00 20/07/2023 79.35%
Watch Steve Moore Premium Only 2023-07-03 11:40:00 03/07/2023